No products in the cart.
Conference Call to be held on Thursday, May 20th, 2021 at 5:00 PM EST NEW [...]
Physician Office Laboratory (POL) Customers will be able to immediately integrate this important test into [...]
Nirmidas’ test is available to POC healthcare providers with an Amazon business account NEW HAVEN, [...]
Precipio reaffirms forecast that product revenues will reach approximately 50% of pathology revenue by the [...]
NEW HAVEN, CT, (April 5th, 2021) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces a new [...]
HemeScreen projected to rapidly become a material revenue contributor in 2021 NEW HAVEN, CT, (March [...]
Conference Call to be held on Wednesday, March 31st, 2021 at 5:00 PM EST NEW [...]
Company Strengthens Depth of Expertise in Products Industry NEW HAVEN, CT, (March 3rd, 2021) – Specialty [...]
NEW HAVEN, CT, (March 3rd, 2021) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the appointment of [...]
Following the receipt of FDA EUA by Nirmidas, Precipio begins market roll out to POC [...]
Username or email address *
Remember me Log in
Lost your password?